Advertisement

Search Results for "Arimidex To Help Boy Growth"

21:25 EDT 18th May 2013 | BioPortfolio

Original Source: Arimidex Multicenter Trial in Growth Hormone (GH) Deficient Boys

The purpose of this study is to see if Arimidex, an aromatase inhibitor, can delay epiphyseal fusion and increase predicted adult height in boys who are growth hormone deficient, in puberty, and who are taking growth hormone. This is a double blind, placebo controlled 3 year trial.

Matching Channels

Tissue Growth Factors BMP 2

The classical tissue factors typically are proteins used for tissue repair and growth stimulation. Among the approved products are the growth factors PDGF, IGF, EGF, BMP and FGF. One of the commercial...

Growth hormone GH

Tumor Growth and Metastasis

Keratinocyte growth factor rDNA

Somatropin Hgh rDNA Pfizer

What is GENOTROPIN? GENOTROPIN (somatropin [rDNA origin] for injection) is a growth hormone treatment. It is an exact copy of the natural growth hormone that our bodies make. The main difference i...

Matching News

Arimidex and Faslodex Combined Show Promise in Metastatic Breast Cancer

The combination of Arimidex® (anastrozole) and Faslodex® (fulvestrant) prolonged overall survival and progression-free survival in postmenopausal women with previously untreated hormone receptor-pos...

AstraZeneca Launches New Digital Resources for ARIMIDEX® (anastrozole) Tablets to Help Educate Patients About ARIMIDEX Direct

AstraZeneca (NYSE: AZN) today launched new digital resources to educate patients on how to enroll in ARIMIDEX Direct. Resources include a “how to” video outlining the e...

FDA approves Afinitor for breast cancer

FDA approved Afinitor everolimus from Novartis AG (NYSE:NVS; SIX:NOVN) in combination with Aromasin exemestane to treat postmenopausal women with hormone receptor-positive, HER2-negative breast cancer...

Drug Combo Slows Breast Cancer Relapse (CME/CE)

(MedPage Today) -- A combination of anastrozole (Arimidex) and fulvestrant (Faslodex) prolonged the time to progression in women with hormone-receptor-positive metastatic breast cancer, researchers re...

Two AstraZeneca breast cancer drugs are better than one

Using a combination of AstraZeneca's aromatase inhibitor, anastrozole (Arimidex) with its oestrogen receptor modulator, Faslodex (fulvestrant) is more effective than either anastrozole alone or seque...

Japan Generics Makers Turn Attention To Versions Of Cancer Drugs

Several Japan-based makers of generic drugs are focusing increasingly on cancer drugs, many of them recently launching their versions of AstraZeneca's Arimidex (anastrozole) for treating breast cancer...

Obesity Could Hinder Breast Cancer Treatment

Women who are obese continue to have higher levels of estrogen despite treatment with aromatase inhibitors such as Arimidex® (anastrozole) and Femara® (letrozole)—and these higher estrogen levels...

AstraZeneca Begins a New Global Study of Faslodex (fulvestrant) Injection in Patients with Hormone Receptor-Positive Advanced Breast Cancer

FALCON (Fulvestrant and AnastrozoLe COmpared in hormonal therapy Naïve advanced breast cancer) trial to compare fulvestrant to ARIMIDEX® (anastrozole) Tablets in hormonal therapy-naïve,...

Matching PubMed Articles

Influence of comorbidities and age on risk of death without recurrence: a retrospective analysis of the arimidex, tamoxifen alone or in combination trial.

PURPOSE The Arimidex, Tamoxifen Alone or in Combination (ATAC) study was a double-blind randomized trial in which postmenopausal women with early-stage breast cancer were assigned to receive anastrozo...

Age effect on bone mineral density changes in breast cancer patients receiving anastrozole: results from the ARBI prospective clinical trial.

PURPOSE: We investigated whether age at anastrozole (A) initiation influences the effect of treatment on bone mineral density (BMD). We conducted a post hoc analysis of the dataset of Arimidex Bone Ma...

Prognostic value of a combined estrogen receptor, progesterone receptor, ki-67, and human epidermal growth factor receptor 2 immunohistochemical score and comparison with the genomic health recurrence score in early breast cancer.

PURPOSE We recently reported that the mRNA-based, 21-gene Genomic Health recurrence score (GHI-RS) provided additional prognostic information regarding distant recurrence beyond that obtained from cla...

Investigation of initial growth of ZnO nanowires and their growth mechanism.

ZnO nanowires were synthesized on Si substrates by a simple metal vapor deposition method without any catalysts. The initial growth and the growth mechanism of the ZnO nanowires were studied using sca...

Taper PbZr(0.2)Ti(0.8)O(3) Nanowire Arrays: From Controlled Growth by Pulsed Laser Deposition to Piezopotential Measurements.

Single crystalline PbZr(0.2)Ti(0.8) (PZT) nanowires arrays (NWAs) with taper morphology were epitaxially grown on SrTiO(3) (STO) substrate using pulse laser deposition. The taper morphology was attrib...

Search Whole site using Google

Loading
Search BioPortfolio:
Advertisement
Advertisement
Advertisement Advertisement